Relay Therapeutics is trading 4.1% up at $19.54 today, driven by broader biotech sector strength and a general market rally despite no fresh company-specific news.
- The SPDR S&P Biotech ETF (XBI) is up approximately 2%, suggesting the stock's move is part of a sector-wide trend.
- Broader market indices are gaining on stronger economic data and easing geopolitical stress, fostering a risk-on environment that typically benefits biotech equities.